{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:47:17Z","timestamp":1771051637915,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jns.2024.123321","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T15:20:43Z","timestamp":1732288843000},"page":"123321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Cerebellar type 1 metabotropic glutamate receptor availability decreases with disease progression in spinocerebellar ataxia type 6"],"prefix":"10.1016","volume":"467","author":[{"given":"Yoshiharu","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jns.2024.123321_bb0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0896-6273(92)90165-A","article-title":"Cellular localization of a metabotropic glutamate receptor in rat brain","volume":"9","author":"Martin","year":"1992","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.jns.2024.123321_bb0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/cne.903220110","article-title":"Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: an in situ hybridization study in adult and developing rat","volume":"322","author":"Shigemoto","year":"1992","journal-title":"J. Comp. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123321_bb0015","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/0896-6273(93)90086-7","article-title":"The metabotropic glutamate receptor (mGluR1 alpha) is concentrated at perisynaptic membrane of neuronal subpopulations as detected by immunogold reaction","volume":"11","author":"Baude","year":"1993","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.jns.2024.123321_bb0020","first-page":"260","article-title":"PET brain kinetics studies of (11)C-ITMM and (11)C-ITDM,radioprobes for metabotropic glutamate receptor type 1, in a nonhuman primate","volume":"4","author":"Yamasaki","year":"2014","journal-title":"Am. J. Nucl. Med. Mol. Imag."},{"issue":"4","key":"10.1016\/j.jns.2024.123321_bb0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-011-1995-6","article-title":"Imaging for metabotropic glutamate receptor subtype 1 in rat and monkey brains using PET with [18F]FITM","volume":"39","author":"Yamasaki","year":"2012","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"2","key":"10.1016\/j.jns.2024.123321_bb0030","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.nucmedbio.2012.11.008","article-title":"Preclinical and the first clinical studies on [11C]ITMM for mapping metabotropic glutamate receptor subtype 1 by positron emission tomography","volume":"40","author":"Toyohara","year":"2013","journal-title":"Nucl. Med. Biol."},{"issue":"8","key":"10.1016\/j.jns.2024.123321_bb0035","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2967\/jnumed.113.119891","article-title":"Initial human PET studies of metabotropic glutamate receptor type 1 ligand 11C-ITMM","volume":"54","author":"Toyohara","year":"2013","journal-title":"J. Nucl. Med."},{"issue":"4","key":"10.1016\/j.jns.2024.123321_bb0040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/pr.108.000166","article-title":"Metabotropic glutamate 1 receptor: current concepts and perspectives","volume":"60","author":"Ferraguti","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jns.2024.123321_bb0045","doi-asserted-by":"crossref","first-page":"416","DOI":"10.12688\/f1000research.10485.1","article-title":"Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease","volume":"6","author":"Kano","year":"2017","journal-title":"F1000Res"},{"issue":"2","key":"10.1016\/j.jns.2024.123321_bb0050","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0092-8674(94)90205-4","article-title":"Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice","volume":"79","author":"Aiba","year":"1994","journal-title":"Cell"},{"issue":"5472","key":"10.1016\/j.jns.2024.123321_bb0055","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1126\/science.288.5472.1832","article-title":"mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination, and motor coordination","volume":"288","author":"Ichise","year":"2000","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.jns.2024.123321_bb0060","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","article-title":"Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis","volume":"95","author":"Spatola","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2024.123321_bb0065","doi-asserted-by":"crossref","first-page":"1142160","DOI":"10.3389\/fneur.2023.1142160","article-title":"Anti-mGluR1 encephalitis: Case illustration and systematic review","volume":"14","author":"Khojah","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.jns.2024.123321_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM200001063420104","article-title":"Paraneoplastic cerebellar ataxia due to autoantibodies against a glutamate receptor","volume":"342","author":"Sillevis Smitt","year":"2000","journal-title":"N. Engl. J. Med."},{"issue":"1\u20132","key":"10.1016\/j.jns.2024.123321_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jns.2015.05.041","article-title":"Decreased metabotropic glutamate receptor type 1 availability in a patient with spinocerebellar ataxia type 6: A (11)C-ITMM PET study","volume":"355","author":"Ishibashi","year":"2015","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2024.123321_bb0080","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00415-016-8248-3","article-title":"Relationship between type 1 metabotropic glutamate receptors and cerebellar ataxia","volume":"263","author":"Ishibashi","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2024.123321_bb0085","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jns.2017.01.036","article-title":"Comparison of imaging using (11)C-ITMM and (18)F-FDG for the detection of cerebellar ataxia","volume":"375","author":"Ishibashi","year":"2017","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2024.123321_bb0090","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","article-title":"Scale for the assessment and rating of ataxia: development of a new clinical scale","volume":"66","author":"Schmitz-Hubsch","year":"2006","journal-title":"Neurology"},{"issue":"3 Pt 1","key":"10.1016\/j.jns.2024.123321_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","article-title":"Simplified reference tissue model for PET receptor studies","volume":"4","author":"Lammertsma","year":"1996","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.jns.2024.123321_bb0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/09298673113209990217","article-title":"In vivo imaging of the metabotropic glutamate receptor 1 (mGluR1) with positron emission tomography: recent advance and perspective","volume":"21","author":"Li","year":"2014","journal-title":"Curr. Med. Chem."},{"issue":"12","key":"10.1016\/j.jns.2024.123321_bb0105","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/01.WCB.0000033967.83623.34","article-title":"Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging","volume":"22","author":"Wu","year":"2002","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.jns.2024.123321_bb0110","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00004728-199007000-00011","article-title":"Correction of PET data for partial volume effects in human cerebral cortex by MR imaging","volume":"14","author":"Meltzer","year":"1990","journal-title":"J. Comput. Assist. Tomogr."},{"issue":"1","key":"10.1016\/j.jns.2024.123321_bb0115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/ng0197-62","article-title":"Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel","volume":"15","author":"Zhuchenko","year":"1997","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.jns.2024.123321_bb0120","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s10038-004-0142-7","article-title":"A clinical and genetic study in a large cohort of patients with spinocerebellar ataxia type 6","volume":"49","author":"Takahashi","year":"2004","journal-title":"J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.jns.2024.123321_bb0125","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S1474-4422(15)00202-1","article-title":"Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study","volume":"14","author":"Jacobi","year":"2015","journal-title":"Lancet Neurol."},{"issue":"Pt 3","key":"10.1016\/j.jns.2024.123321_bb0130","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/brain\/aws369","article-title":"I. axia Study Group, Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1","volume":"136","author":"Reetz","year":"2013","journal-title":"SCA3 and SCA6, Brain"},{"key":"10.1016\/j.jns.2024.123321_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2023.119950","article-title":"Age-related differences of cerebellar cortex and nuclei: MRI findings in healthy controls and its application to spinocerebellar ataxia (SCA6) patients","volume":"270","author":"Jaschke","year":"2023","journal-title":"Neuroimage"},{"issue":"7","key":"10.1016\/j.jns.2024.123321_bb0140","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00415-006-0383-9","article-title":"Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6\u202f: a voxel-based FDG-positron emission tomography analysis","volume":"254","author":"Wang","year":"2007","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2024.123321_bb0145","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archneur.61.6.933","article-title":"Quantitative assessment of cerebral blood flow in genetically confirmed spinocerebellar ataxia type 6","volume":"61","author":"Honjo","year":"2004","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.jns.2024.123321_bb0150","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/hbm.23210","article-title":"Alteration of the regional cerebral glucose metabolism in healthy subjects by glucose loading","volume":"37","author":"Ishibashi","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"5","key":"10.1016\/j.jns.2024.123321_bb0155","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1021\/jm201590g","article-title":"Synthesis and evaluation of novel radioligands for positron emission tomography imaging of metabotropic glutamate receptor subtype 1 (mGluR1) in rodent brain","volume":"55","author":"Fujinaga","year":"2012","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.jns.2024.123321_bb0160","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.neuropharm.2004.08.007","article-title":"JNJ16259685, a highly potent, selective and systemically active mGlu1 receptor antagonist","volume":"47","author":"Lavreysen","year":"2004","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.jns.2024.123321_bb0165","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1523\/JNEUROSCI.3542-13.2014","article-title":"The synaptic targeting of mGluR1 by its carboxyl-terminal domain is crucial for cerebellar function","volume":"34","author":"Ohtani","year":"2014","journal-title":"J. Neurosci."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2400457X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X2400457X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T09:25:56Z","timestamp":1733909156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X2400457X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":33,"alternative-id":["S0022510X2400457X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123321","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebellar type 1 metabotropic glutamate receptor availability decreases with disease progression in spinocerebellar ataxia type 6","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123321"}}